Nimbus Therapeutics

Nimbus Therapeutics

Nimbus Therapeutics

Biotech company harnessing the power of computational chemistry to design breakthroughs for serious, underserved diseases.
Type
B2c
Founded
2009
Raised
$89M
Follow us
Alexa global traffic share
Twitter followers
05 Jun 2018
$65,000,000
Venture capital (Series C)

Biotech Company Nimbus Therapeutics Secures $65M in Funding

FinSMEs
+1
28 Jun 2011
$24,000,000
Venture capital (Series A)